Bessemer Group Inc Adma Biologics, Inc. Transaction History
Bessemer Group Inc
- $55.8 Billion
- Q1 2025
A detailed history of Bessemer Group Inc transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 486 shares of ADMA stock, worth $11,911. This represents 0.0% of its overall portfolio holdings.
Number of Shares
486
Previous 561
13.37%
Holding current value
$11,911
Previous $10,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ADMA
# of Institutions
349Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$457 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$446 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$364 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$277 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$136 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $4.81B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...